Thorne HealthTech, Inc. (THRN) Misses Q3 EPS by 1c; Offers FY22 Guidance

Thorne HealthTech, Inc. (NASDAQ: THRN) reported Q3 EPS of $0.12, $0.01 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $58.4 million versus the consensus estimate of $63.25 million.

GUIDANCE:

Thorne HealthTech, Inc. sees FY2022 EPS of $0.34-$0.37, versus the consensus of $0.36. Thorne HealthTech, Inc. sees FY2022 revenue of $232-235 million, versus the consensus of $238 million.

For earnings history and earnings-related data on Thorne HealthTech, Inc. (THRN) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c